Clinical outcomes of carvedilol versus metoprolol in patients with heart failure with preserved ejection fraction following myocardial infarction
Optimal beta-blocker selection in patients with heart failure with preserved ejection fraction (HFpEF) following acute myocardial infarction (MI) remains uncertain. While both carvedilol and metoprolol are commonly prescribed, comparative effectiveness data in HFpEF are limited. We evaluated 3-year cardiovascular...